| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And CEO | President &CEO | Chief Operating Officer
1 company
Campbell Bradley L is a President And CEO at AMICUS THERAPEUTICS, INC.. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $14.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 1, 2021 | FOLD Amicus Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 10,514 | $10.03 | $105,504.84 | -2.7% | -4.2% | -6.3% | |
| Mar 1, 2021 | FOLD Amicus Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 10,514 | $11.84 | $124,516.25 | -2.7% | - | - | |
| Feb 1, 2021 | FOLD Amicus Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 10,514 | $19.08 | $200,571.37 | -2.7% | - | - | |
| Jan 4, 2021 | FOLD Amicus Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 10,514 | $22.17 | $233,124.82 | -3.3% | - | - | |
| Dec 1, 2020 | FOLD Amicus Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 24,783 | $22.77 | $564,192.43 | -6.8% | - | - | |
| Nov 2, 2020 | FOLD Amicus Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 24,782 | $17.87 | $442,792.39 | -6.8% | - | - | |
| Sep 28, 2020 | FOLD Amicus Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 24,782 | $13.89 | $344,204.63 | -6.8% | - | - | |
| Aug 3, 2020 | FOLD Amicus Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 10,000 | $14.78 | $147,779.00 | -2.9% | - | - | |
| Jul 8, 2020 | FOLD Amicus Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 2,500 | $16.01 | $40,025.00 | -0.7% | - | - | |
| Jul 1, 2020 | FOLD Amicus Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 12,500 | $15.47 | $193,383.75 | -3.6% | - | - |